Table 1 | Fibre in diverticulosis and symptomatic diverticular disease

Slides:



Advertisements
Similar presentations
FRISC II: Fragmin and fast Revascularization during InStability in Coronary artery disease - LONG-TERM HEPARIN - Purpose To assess efficacy of long-term.
Advertisements

BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
A daily dose of 400 mg efavirenz (EFV) is non-inferior to the standard 600 mg dose: week 48 data from the ENCORE1 study, a randomised, double-blind, placebo.
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
CONSENSUS: Cooperative North Scandinavian Enalapril Survival Study Purpose To determine whether the ACE inhibitor enalapril reduces mortality in patients.
CAPRIE: Clopidogrel versus Aspirin in Patients at risk of Ischemic Events Purpose To assess the relative efficacy of the antiplatelet drugs clopidogrel.
SOLVD (Studies of Left Ventricular Dysfunction)
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Randomized, double-blind, multicenter, controlled trial.
Diverticulosis and Diverticulitis
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
Gabrielle Sherer Cardiovascular Risk Reduction Jeff Luckring MS, RD.
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
Dr Richard Downey Ms McNamara service.  Short term Results of the Sigma Trial  Bastiaan R. Klarenbeek MD et al  Annals of Surgery, January 2009  Ann.
How to Analyze Therapy in the Medical Literature (part 1) Akbar Soltani. MD.MSc Tehran University of Medical Sciences (TUMS) Shariati Hospital
4S: Scandinavian Simvastatin Survival Study
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
COPERNICUS: Carvedilol Prospective Randomized Cumulative Survival trial Purpose To assess the effect of carvedilol, a β 1 -, β 2 - and α 1 -receptor blocker,
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
Comprehensive moUth hygiene and Post- operative PneumoniA (CUPPA)
Section 4: Managing progression of CKD
Table 1 | Fibre in diverticulosis and symptomatic diverticular disease
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
Study Trial design No. of patients Randomisation Outcomes assessed
Study Trial design No. of patients Randomisation Outcomes assessed
Study Trial design No. of patients Randomisation Outcomes assessed
LEADER trial: Primary Outcome
HOPE: Heart Outcomes Prevention Evaluation study
Neal B, et al. Diabetes Care 2015;38:403–411
CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
FATS- Familial Atherosclerosis Treatment Study
Nurses' Health Study: Risk of hypertension associated with >1000 µg/day of folate vs
Coffee drinking and leukocyte telomere length: A meta-analysis
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Timothy A. Brighton, M. B. , B. S. , John W. Eikelboom, M. B. , B. S
CRASH 2 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2):
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Volume 147, Issue 4, Pages (October 2014)
NOACS: Emerging data in ACS/IHD
PARTNER 2A Trial design: Intermediate-risk patients with aortic stenosis (STS PROM score 4-8%) were randomized to undergo either TAVR or SAVR, stratified.
Section 7: Aggressive vs moderate approach to lipid lowering
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
ATMOSPHERE Trial design: Patients with symptomatic heart failure were randomized in a 1:1:1 fashion to either aliskiren 300 mg once daily, enalapril 5.
CIBIS II: Cardiac Insufficiency Bisoprolol Study II
Eating Your Way to Improve Your Health: Breakfast
RIDDLE-NSTEMI Trial design: Patients with NSTEMI were randomized to either immediate (within 2 hours) intervention or delayed (within 72 hours) intervention.
Section overview: Cardiometabolic risk reduction
Screening, Lipid Stabilization, and Placebo Run-in
Efficacy and safety of niacin/laropiprant
OSLER Trial design: Patients from five phase 2 trials and seven phase 3 trials with evolocumab were invited to participate in the OSLER extension program,
19,628 operations in NSW for LSS between 2003 and 2013
Diverticulosis Outpouchings of intestinal wall
LRC-CPPT and MRFIT Content Points:
Effect of supplementation with SeMet or SY on plasma selenium levels in adult men. Effect of supplementation with SeMet or SY on plasma selenium levels.
Indications: Complicated DD after 6/52
The efficacy and safety of omalizumab in pediatric allergic asthma
PRESENTER: Quynh vu, pgy-2
IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Stavros V. Konstantinides et al. JACC 2017;69:
Presentation data from US VICTORY Consortium
Section C: Clinical trial update: Oral antiplatelet therapy
Medical Scientific Experts
Presentation transcript:

Table 1 | Fibre in diverticulosis and symptomatic diverticular disease Study Trial design No. of patients Randomisation Outcomes assessed Length of follow-up Results Brodibb Double-blind 18 Wheat crispbread 0.6 g/day vs. bran crisp Bread 6.7 g/day Reduction in global symptom score in SUDD 3 months High fibre vs. low fibre group has significant reduction in symptoms score (34.3–8.1 vs. 42.0–35.1, P < 0.002) Ornstein et al. Randomised, cross-over, double-blind, Placebo controlled 58 Bran (6.99 g/day) vs. ispaghula (9.04 g/day) vs. placebo (2.34 g/day) Reduction in global symptom score in SUDD 16 weeks No difference was found between the three arms (from 16.3, 18.4 and 15.6–5.9, 6.7 and 6.3, P = n.s.). No difference between bran and ispaghula consumption (5.9 vs. 6.7) Hodgson Double-blind, randomised, Placebo controlled 30 Methylcellulose 2 tablets/day vs. placebo 2 tablets/day Reduction in global symptom score in SUDD Symptom score decreased significantly in the methylcellulose group (from 19 + 6 to 13+ 4, P < 0.01) but not in the placebo group (from 21+ 7 to 17 + 9, P = n.s.) Crowe Prospective, cohort study 47.033 Vegetarian vs. Non vegetarian diet (≥25.5 g/day for Women and ≥26.1 g/day for men) vs. lower fibre consumption Occurrence of DD; Hospital admission for DD complications 11.6 years Vegetarians had a 31% lower risk of DD occurrence (P = 0.001)High fibre intake had a 26% lower risk of developing DD (P = 0.018). Hospital admission or death for DD was 4.4% for meat eaters and 3.0% in vegetarians or vegans Peery Cross-sectional study 2104 Fibre or high Fibre Consumption (>50 g/day) vs. normal diet Diverticulosis occurrence 12 years High fibre consumption had higher risk to develop diverticulosis (P = 0.004) Soluble fibre had higher risk to develop diverticulosis (P = 0.038) Strate Prospective 47.228 Lower (less than once per month) vs. Higher (at least twice per week) nut, corn, or popcorn consumption Diverticulitis occurrence Diverticular bleeding occurrence 18 years Higher nut, corn or popcorn consumption had lower risk of diverticulitis occurrence (P = 0.034). No difference in diverticular bleeding occurrence between higher or lower consumption of nut, corn or popcorn (P = 0.56, 0.64 and 0.52 respectively) Leahy case–control 56 Lower (<25 g/day) vs. High (>25 /day) fibre diet Symptoms recurrence Occurrence of complications Surgery due to DD 66 months High fibre diet has significantly lower symptom recurrence (19.35% vs. 44%, P < 0.05), occurrence of complications (6.45% vs, 20.25%, P < 0.05) and surgery due to DD (6.45% vs. 32%) than low fibre diet SUDD, Symptomatic Uncomplicated Diverticular Disease; DD, Diverticular Disease. .